Anton Forsberg Morén

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Enhetschef för Core Facility Brain Molecular Imaging Center (BMIC). Forskare i forskargruppen Varrone som arbetar inom avbildningstekniken Positron Emission Tomography (PET).

Forskningsbeskrivning

Min huvudsakliga forskning är att använda neuroimaging inom neurodegenerativa sjukdomar, främst inklusive Alzeimers sjukdom (AD) samt andra sjukdomar som Parkinsons sjukdom (PD) och Huntingtons sjukdom (HD). Den huvudsakliga metoden som används är Positron Emission Tomography (PET) som använder olika biomarkörer för Amyloid, Tau och radioligander för neuroinflammation, etc.

Mina första år i PET-forskningen inkluderade världens första studier av in vivo amyloid PET-avbildning vid mild kognitiv funktionsnedsättning (MCI) och longitudinella förändringar av amyloidbelastningen i AD. Jag har därefter fortsatt AD-forskning vid Karolinska PET-centret i Solna inklusive flera projekt med fokus på utvärdering och applicering av nya PET-radioligander riktade mot amyloida och neuroinflammatoriska mål såsom Translocator-proteinet (TSPO) i mikroglia. Förutom mitt fokus på AD har jag varit och är för närvarande involverad i många andra projekt inklusive studier av patologiska förändringar i PD undersöker de serotonerga och dopaminerga systemen och neuroinflammation, samt utvecklar nya radioligander riktade mot mutanter huntingtin i HD.
Under min 19 år långa karriär inom PET-forskning har jag blivit expert på dataanalys och modellering av PET-data hos människor såväl som primater. Som en del av mitt arbete här på Karolinska Institutet PET-center har jag även arbetat mycket med projektledning av akademiska projekt samt samarbeten med industriella partners. Därför är mitt engagemang och uppgifter inom denna applikation tydligt kopplade till både mina intressen inom forskningsfälten samt min expertis inom PET-dataanalys och projektledning.

Undervisning

Arrangör av den drygt en vecka långa forskarutbildningskursen "Positron Emission Tomography Imaging of the CNS. Metodik och kliniska tillämpningar".
Medarrangör av masterkursen "Introduktion till hjärnavbildning i neurovetenskap: Med fokus på MRI, PET, EEG och MEG metoder".

Artiklar

Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2025;12(8):100302
Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers
Nery FC; Kaliszczak M; Suttle B; Jones L; Wu S; Xie J; Curiale G; Yesilalan E; Hirschhorn B; Wilkes D; Singh D; Bolin M; Nag S; Varrone A; Stenkrona P; Halldin C; Yachnin J; Arnold HM; Bullain S; Landen J; Gallagher D; Hering H
Article: JOURNAL OF NUCLEAR MEDICINE. 2025;:jnumed.125.269671
Imaging Proinflammatory Microglia in Parkinson Disease Using [11C]SMW139 PET: A Multicenter Study.
Rikken RM; van de Giessen E; Brumberg J; Aarnio R; Joling M; Forsberg Morén A; Kerstens V; Moein MM; Nag S; Halldin C; Fazio P; Roos DS; Berendse HW; Kassiou M; Wahlroos S; Haaparanta-Solin M; Oikonen V; Schuit RC; Boellaard R; Windhorst AD; Jacobs AH; Lammertsma AA; Rinne JO; Varrone A; Golla SSV
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025;45(8):1606-1616
In vivo quantification of [¹¹C]BIO-1819578 in non-human primates, a novel radioligand for O-GlcNAcase
Bolin M; Nag S; Arakawa R; Varrone A; Farde L; Martarello L; Kaliszczak MA; Halldin C; Moren AF
Article: PCN REPORTS. 2025;4(2):e70123
[¹⁸F]FE-PE2I PET is a diagnostic tool in dementia with Lewy bodies
Sturchio A; Svensson JE; Tiger M; Moren AF; Varrone A; Svenningsson P; Okubo Y; Tateno A
Article: SCIENCE TRANSLATIONAL MEDICINE. 2025;17(797):eadl1732
PET imaging of antisense oligonucleotide distribution in rat and nonhuman primate brains using click chemistry
Cook BE; Pickel TC; Nag S; Bolduc PN; Beshr R; Moren AF; Muste C; Boscutti G; Jiang D; Yuan L; Datta P; Ochniewicz P; Meynaq YK; Tang S-P; Plisson C; Amatruda M; Zhang Q; DuBois JM; Delavari A; Klein SK; Polyak I; Shoroye A; Girmay S; Halldin C; Martarello L; Peterson EA; Kaliszczak M
Article: MOVEMENT DISORDERS. 2025;40(4):739-744
Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [¹¹C]PBR28 PET
Wallin J; Forsberg A; Svenningsson P
Article: MOLECULES. 2025;30(6):1356
Good Manufacturing Practice Validation and Radiation Dosimetry for the Clinical Application of a Novel α7-nAChR Radioligand: [¹¹C]KIn83
Jia Z; Bolin M; Moren AF; Datta P; Asem H; Agren H; Langstrom B; Nordberg A; Halldin C; Nag S
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025;45(2):352-364
Imaging the 5-HT_2C receptor with PET: Evaluation of 5-HT_2C and 5-HT_2A affinity of pimavanserin in the primate brain
Ridler K; Rizzo G; Burstein ES; Forsberg Moren A; Stepanov V; Halldin C; Rabiner EA
Article: ACS CHEMICAL NEUROSCIENCE. 2024;15(22):4210-4219
Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand
Guarino DS; Azpiazu PM; Sunnemark D; Elmore CS; Bergare J; Artelsmair M; Nordvall G; Moren AF; Jia Z; Cortes-Gonzalez M; Mach R; Wilcox KC; Finnema S; Schou M; Varrone A
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024;25(14):7870
Labeling of Bruton's Tyrosine Kinase (BTK) Inhibitor [¹¹C]BIO-2008846 in Three Different Positions and Measurement in NHP Using PET
Nag S; Datta P; Moren AF; Khani Y; Martarello L; Kaliszczak M; Halldin C
Article: JOURNAL OF ALZHEIMERS DISEASE. 2024;98(4):1391-1401
High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer's Disease Using [¹¹C]AZD2184
Mattsson P; Cselenyi Z; Moren AF; Freund-Levi Y; Wahlund L-O; Halldin C; Farde L
Article: BMC NEUROLOGY. 2024;24(1):111
Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol
Svensson JE; Bolin M; Thor D; Williams PA; Brautaset R; Carlsson M; Sorensson P; Marlevi D; Spin-Neto R; Probst M; Hagman G; Moren AF; Kivipelto M; Plaven-Sigray P
Article: EJNMMI PHYSICS. 2023;10(1):72
Parametric and non-parametric Poisson regression for modelling of the arterial input function in positron emission tomography
Matheson GJ; Ge L; Zhang M; Sun B; Tu Y; Zanderigo F; Moren AF; Ogden RT
Article: JOURNAL OF NUCLEAR MEDICINE. 2023;64(10):1588-1593
Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain
Cook BE; Nag S; Arakawa R; Lin EY-S; Stratman N; Guckian K; Hering H; Lulla M; Choi J; Salinas C; Genung NE; Moren AF; Bolin M; Boscutti G; Plisson C; Martarello L; Halldin C; Kaliszczak MA
Article: ACS CHEMICAL NEUROSCIENCE. 2023;14(14):2560-2568
Development of a Novel [¹¹C]CO-Labeled Positron Emission Tomography Radioligand [¹¹C]BIO-1819578 for the Detection of O-GlcNAcase Enzyme Activity
Nag S; Bolin M; Datta P; Arakawa R; Moren AF; Maynaq YK; Lin E; Genung N; Hering H; Guckian K; Martarello L; Kaliszczak M; Halldin C
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2023;43(2):258-268
Quantification of the purinergic P2X₇ receptor with [¹¹C]SMW139 improves through correction for brain-penetrating radiometabolites
Brumberg J; Aarnio R; Forsberg A; Marjamaki P; Kerstens V; Moein MM; Nag S; Wahlroos S; Kassiou M; Windhorst AD; Halldin C; Haaparanta-Solin M; Fazio P; Oikonen V; Rinne JO; Varrone A
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2023;66(1):641-656
Design and Evaluation of [18F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin Aggregates
Liu L; Johnson PD; Prime ME; Khetarpal V; Brown CJ; Anzillotti L; Bertoglio D; Chen X; Coe S; Davis R; Dickie AP; Esposito S; Gadouleau E; Giles PR; Greenaway C; Haber J; Halldin C; Haller S; Hayes S; Herbst T; Herrmann F; Hessmann M; Hsai MM; Khani Y; Kotey A; Lembo A; Mangette JE; Marriner GA; Marston RW; Mills MR; Monteagudo E; Forsberg-Moren A; Nag S; Orsatti L; Sandiego C; Schaertl S; Sproston J; Staelens S; Tookey J; Turner PA; Vecchi A; Veneziano M; Munoz-Sanjuan I; Bard J; Dominguez C
Article: ACS CHEMICAL NEUROSCIENCE. 2022;13(14):2078-2083
Synthesis and Preclinical Evaluation of [¹¹C]AZ11895530 for PET Imaging of the Serotonin 1A Receptor
Dahl K; Johnstrom P; Forsberg-Moren A; Gustafsson B; Miranda-Azpiazu P; Khani Y; Halldin C; Farde L; Elmore CS; Schou M
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2021;64(16):12003-12021
[¹¹C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins
Liu L; Johnson PD; Prime ME; Khetarpal V; Lee MR; Brown CJ; Chen X; Clark-Frew D; Coe S; Conlon M; Davis R; Ensor S; Esposito S; Moren AF; Gai X; Green S; Greenaway C; Haber J; Halldin C; Hayes S; Herbst T; Herrmann F; He-mann M; Hsai MM; Kotey A; Mangette JE; Mills MR; Monteagudo E; Nag S; Nibbio M; Orsatti L; Schaertl S; Scheich C; Sproston J; Stepanov V; Varnas K; Varrone A; Wityak J; Mrzljak L; Munoz-Sanjuan I; Bard JA; Dominguez C
Article: NATURE AND SCIENCE OF SLEEP. 2021;13:775-789
Objective and Subjective Sleep in Rheumatoid Arthritis and Severe Seasonal Allergy: Preliminary Assessments of the Role of Sickness, Central and Peripheral Inflammation
Tamm S; Lensmar C; Andreasson A; Axelsson J; Moren AF; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Hoglund CO; Strand V; Cervenka S; Lekander M
Article: MOVEMENT DISORDERS. 2020;35(4):606-615
PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progression
Fazio P; Fitzer-Attas CJ; Mrzljak L; Bronzova J; Nag S; Warner JH; Landwehrmeyer B; Al-Tawil N; Halldin C; Forsberg A; Ware J; Dilda V; Wood A; Sampaio C; Varrone A; Svenningsson P; Paucar M; Sundblom J; Nyholm D; Widner H; Heiberg A; Frich J; Nielsen J; Hjermind L; Roos R
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(11):2329-2338
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [¹¹C]PBR28 HRRT PET study
Tuisku J; Plaven-Sigray P; Gaiser EC; Airas L; Al-Abdulrasul H; Bruck A; Carson RE; Chen M-K; Cosgrove KP; Ekblad L; Esterlis I; Farde L; Forsberg A; Halldin C; Helin S; Kosek E; Lekander M; Lindgren N; Marjamaki P; Rissanen E; Sucksdorff M; Varrone A; Collste K; Gallezot J-D; Hillmer A; Huang Y; Hoglund CO; Johansson J; Jucaite A; Lampa J; Nabulsi N; Pittman B; Sandiego CM; Stenkrona P; Rinne J; Matuskey D; Cervenka S
Article: JOURNAL OF NEUROIMMUNOLOGY. 2019;334:577000
Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [¹¹C]PBR28 positron emission tomography
Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Hoglund OC; Kosek E
Article: MOLECULAR IMAGING AND BIOLOGY. 2019;21(3):500-508
Characterization of [¹¹C]PXT012253 as a PET Radioligand for mGlu₄ Allosteric Modulators in Nonhuman Primates
Takano A; Nag S; Jia Z; Jahan M; Forsberg A; Arakawa R; Gryback P; Duvey G; Halldin C; Charvin D
Article: NEUROIMAGE. 2019;188:102-110
Accuracy and reliability of [¹¹C]PBR28 specific binding estimated without the use of a reference region
Plaven-Sigray P; Schain M; Zanderigo F; Farde L; Halldin C; Forsberg A; Varrone A; Jucaite A; Cervenka S; Stenkrona P; Collste K; Kander M; Kosek E; Lampa J; Hoglund CO; Rabiner EA; Gunn RN; Ogden RT; Cervenk S
Article: BRAIN BEHAVIOR AND IMMUNITY. 2019;75:72-83
Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation
Albrecht DS; Forsberg A; Sandstrom A; Bergan C; Kadetoff D; Protsenko E; Lampa J; Lee YC; Hoglund CO; Catana C; Cervenka S; Akeju O; Lekander M; Cohen G; Halldin C; Taylor N; Kim M; Hooker JM; Edwards RR; Napadow V; Kosek E; Loggia ML
Article: BRAIN BEHAVIOR AND IMMUNITY. 2018;68:146-157
Evidence of fatigue, disordered sleep and peripheral inflammation, but not increased brain TSPO expression, in seasonal allergy: A [¹¹C]PBR28 PET study
Tamm S; Cervenka S; Forsberg A; Estelius J; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Lensmar C; Strand V; Akerstedt T; Halldin C; Ingvar M; Hoglund CO; Lekander M
Article: EJNMMI RESEARCH. 2017;7(1):58
Assessment of simplified ratio-based approaches for quantification of PET [¹¹C] PBR28 data
Matheson GJ; Plaven-Sigray P; Forsberg A; Varrone A; Farde L; Cervenka S
Article: MOLECULAR PSYCHIATRY. 2017;22(6):850-856
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [¹¹C]PBR28
Collste K; Plaven-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(5):462-469
Extrastriatal dopamine D2-receptor availability in social anxiety disorder
Plaven-Sigray P; Hedman E; Victorsson P; Matheson GJ; Forsberg A; Djurfeldt DR; Ruck C; Halldin C; Lindefors N; Cervenka S
Article: NEUROPHARMACOLOGY. 2017;117:171-181
In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects
Delnomdedieu M; Forsberg A; Ogden A; Fazio P; Yu C-R; Stenkrona P; Duvvuri S; David W; Al-Tawil N; Vitolo OV; Amini N; Nag S; Halldin C; Varrone A
Article: ANNALS OF NEUROLOGY. 2017;81(4):572-582
The Immune Response of the Human Brain to Abdominal Surgery
Forsberg A; Cervenka S; Fagerlund MJ; Rasmussen LS; Zetterberg H; Harris HE; Stridh P; Christensson E; Granstrom A; Schening A; Dymmel K; Knave N; Terrando N; Maze M; Borg J; Varrone A; Halldin C; Blennow K; Farde L; Eriksson LI
Article: JOURNAL OF NUCLEAR MEDICINE. 2017;58(4):617-622
Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex
Haggkvist J; Toth M; Tari L; Varnas K; Svedberg M; Forsberg A; Nag S; Dominguez C; Munoz-Sanjuan I; Bard J; Wityak J; Varrone A; Halldin C; Mrzljak L
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2017;44(3):382-391
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline
Sturm S; Forsberg A; Nave S; Stenkrona P; Seneca N; Varrone A; Comley RA; Fazio P; Jamois C; Nakao R; Ejduk Z; Al-Tawil N; Akenine U; Halldin C; Andreasen N; Ricci B
Article: PSYCHIATRY RESEARCH-NEUROIMAGING. 2016;253:36-42
Low serotonin_1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder
Tiger M; Farde L; Ruck C; Varrone A; Forsberg A; Lindefors N; Halldin C; Lundberg J
Article: BRAIN BEHAVIOR AND IMMUNITY. 2016;54:149-157
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects
Kanegawa N; Collste K; Forsberg A; Schain M; Arakawa R; Jucaite A; Lekander M; Hoglund CO; Kosek E; Lampa J; Halldin C; Farde L; Varrone A; Cervenka S
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2016;43(1):173-183
Test-retest reproducibility of [¹¹C]PBR28 binding to TSPO in healthy control subjects
Collste K; Forsberg A; Varrone A; Amini N; Aeinehband S; Yakushev I; Halldin C; Farde L; Cervenka S
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2015;42(10):1507-1511
β-Amyloid binding in elderly subjects with declining or stable episodic memory function measured with PET and [¹¹C]AZD2184
Mattsson P; Forsberg A; Persson J; Nyberg L; Nilsson L-G; Halldin C; Farde L
Article: SYNAPSE-STRUCTURE FUNCTION CONNECTIVITY. 2015;69(7):365-374
5-HT_1B receptor imaging and cognition: A positron emission tomography study in control subjects and parkinson's disease patients
Varrone A; Svenningsson P; Marklund P; Fatouros-Bergman H; Forsberg A; Halldin C; Nilsson L-G; Farde L
Article: JOURNAL OF NUCLEAR MEDICINE. 2015;56(5):714-720
Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4′-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease
Fazio P; Svenningsson P; Forsberg A; Jonsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
Article: JOURNAL OF CLINICAL INVESTIGATION. 2015;125(3):1339-1346
Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients
Paul G; Zachrisson O; Varrone A; Almqvist P; Jerling M; Lind G; Rehncrona S; Linderoth B; Bjartmarz H; Shafer LL; Coffey R; Svensson M; Mercer KJ; Forsberg A; Halldin C; Svenningsson P; Widner H; Frisen J; Palhagen S; Haegerstrand A
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2015;42(3):438-446
Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [¹⁸F]FEMPA in Alzheimer's disease patients and control subjects
Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
Article: NEUROIMAGE. 2014;103:303-308
Distinct regional age effects on [¹¹C]AZ10419369 binding to 5-HT_1B receptors in the human brain
Nord M; Cselenyi Z; Forsberg A; Rosenqvist G; Tiger M; Lundberg J; Varrone A; Farde L
Article: PSYCHIATRY RESEARCH. 2014;223(2):164-170
Reduced 5-HT_1B receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder
Tiger M; Ruck C; Forsberg A; Varrone A; Lindefors N; Halldin C; Farde L; Lundberg J
Article: NEUROBIOLOGY OF AGING. 2014;35(4):867-875
Positron emission tomography imaging of 5-hydroxytryptamine_1B receptors in Parkinson's disease
Varrone A; Svenningsson P; Forsberg A; Varnas K; Tiger M; Nakao R; Halldin C; Nilsson L-G; Farde L
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2013;33(7):1058-1065
Arterial input function derived from pairwise correlations between PET-image voxels
Schain M; Benjaminsson S; Varnas K; Forsberg A; Halldin C; Lansner A; Farde L; Varrone A
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;40(6):921-931
In vivo imaging of the ¹⁸-kDa translocator protein (TSPO) with [¹⁸F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients
Varrone A; Mattsson P; Forsberg A; Takano A; Nag S; Gulyas B; Borg J; Boellaard R; Al-Tawil N; Eriksdotter M; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Lammertsma AA; Halldin C
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;40(4):580-593
Low background and high contrast PET imaging of amyloid-β with [¹¹C]AZD2995 and [¹¹C]AZD2184 in Alzheimer's disease patients
Forsberg A; Jureus A; Cselenyi Z; Eriksdotter M; Freund-Levi Y; Jeppsson F; Swahn B-M; Sandell J; Julin P; Schou M; Andersson J; Johnstrom P; Varnas K; Halldin C; Farde L; Svensson S
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;40(1):104-114
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Nordberg A; Carter SF; Rinne J; Drzezga A; Brooks DJ; Vandenberghe R; Perani D; Forsberg A; Langstrom B; Scheinin N; Karrasch M; Nagren K; Grimmer T; Miederer I; Edison P; Okello A; Van Laere K; Nelissen N; Vandenbulcke M; Garibotto V; Almkvist O; Kalbe E; Hinz R; Herholz K
Article: JOURNAL OF NUCLEAR MEDICINE. 2012;53(3):415-424
Clinical Validation of ¹⁸F-AZD4694, an Amyloid-β-Specific PET Radioligand
Cselenyi Z; Jonhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnstrom P; Varnas K; Svensson S; Farde L
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2012;1822(3):380-385
The use of PIB-PET as a dual pathological and functional biomarker in AD
Forsberg A; Engler H; Blomquist G; Langstrom B; Nordberg A
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2012;33(2-3):156-163
CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly
Stomrud E; Forsberg A; Hagerstrom D; Ryding E; Blennow K; Zetterberg H; Minthon L; Hansson O; Londos E
Article: NEUROBIOLOGY OF AGING. 2012;33(1):198.e1-198.14
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease
Kadir A; Almkvist O; Forsberg A; Wall A; Engler H; Langstrom B; Nordberg A
Article: NEUROBIOLOGY OF AGING. 2011;32(12):2320.e15-2320.e32
Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo
Darreh-Shori T; Forsberg A; Modiri N; Andreasen N; Blennow K; Kamil C; Ahmed H; Almkvist O; Langstrom B; Nordberg A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2011;24(1):109-123
Long-term Effects of Galantamine Treatment on Brain Functional Activities as Measured by PET in Alzheimer's Disease Patients
Keller C; Kadir A; Forsberg A; Porras O; Nordberg A
Article: CURRENT ALZHEIMER RESEARCH. 2010;7(1):56-66
High PIB Retention in Alzheimer's Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
Forsberg A; Almkvist O; Engler H; Wall A; Langstrom B; Nordberg A
Article: OPEN NEUROIMAGING JOURNAL. 2008;2:114-125
Unidirectional Influx and Net Accumulation of PIB.
Blomquist G; Engler H; Nordberg A; Ringheim A; Wall A; Forsberg A; Estrada S; Frändberg P; Antoni G; Långström B
Article: NEUROBIOLOGY OF AGING. 2008;29(10):1456-1465
PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg A; Engler H; Almkvist O; Blomquist G; Hagman G; Wall A; Ringheim A; Langstrom B; Nordberg A
Article: ANNALS OF NEUROLOGY. 2008;63(5):621-631
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
Kadir A; Andreasen N; Almkvist O; Wall A; Forsberg A; Engler H; Hagman G; Larksater M; Winblad B; Zetterberg H; Blennow K; Langstrom B; Nordberg A
Article: PARKINSONISM & RELATED DISORDERS. 2008;14(4):345-347
[¹¹C]-PIB imaging in patients with Parkinson's disease:: Preliminary results
Johansson A; Savitcheva I; Forsberg A; Engler H; Langstrom B; Nordberg A; Askmark H
Journal article: BRAIN. 2006;129(Pt 11):2805-2807
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Klunk WE; Mathis CA; Price JC; Lopresti BJ; DeKosky ST
Article: BRAIN. 2006;129(Pt 11):2856-2866
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Langstrom B; Nordberg A
Journal article: MOLECULAR IMAGING AND BIOLOGY. 2006;8(2):49-123
Molecular imaging and biology
Article: JOURNAL OF NEURAL TRANSMISSION. 2006;113(2):205-218
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease
Stefanova E; Wall A; Almkvist O; Nilsson A; Forsberg A; Långström B; Nordberg A
Visa fler

Alla övriga publikationer

Preprint: MEDRXIV. 2024
Evaluating the effect of rapamycin treatment in Alzheimer's Disease and aging usingin vivoimaging: the ERAP phase IIa clinical study protocol
Svensson J; Bolin M; Thor D; Williams P; Brautaset R; Carlsson M; Sörensson P; Marlevi D; Spin-Neto R; Probst M; Hagman G; Morén AF; Kivipelto M; Plavén-Sigray P
Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S26
Synthesis and biological evaluation of a novel radioligand [¹¹C]BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity
Nag S; Arakawa R; Datta P; Moren A; Varrone A; Moein MM; Bolin M; Lin E; Genung N; Martarello L; Kaliszczak M; Halldin C
Corrigendum: MOVEMENT DISORDERS. 2020;35(12):2363-2364
PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression (vol 35, pg 606, 2020)
Fazio P; Fitzer-Attas CJ; Mrzljak L; Bronzova J; Nag S; Warner JH; Landwehrmeyer B; Al-Tawil N; Halldin C; Forsberg A; Ware J; Dilda V; Wood A; Sampaio C; Varrone A
Editorial comment: BRAIN. 2020;143(9):2634-2636
Timing is everything: tau imaging across stages of Alzheimer's disease
Moren AF; Varrone A
Meeting abstract: NEUROIMAGE. 2010;52:S142
Quantification and wavelet-aided parametric imaging of cerebral amyloid using the HRRT PET-system and [18F]AZD4694
Cselenyi Z; Jonhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnstroem P; Varnas K; Svensson S; Farde L
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2009;19:S125-S126
Time course in evolution of brain amyloid and its relation to cognitive impairment in Alzheimer's disease
Nordberg A; Forsberg A; Kadir A; Almkvist O; Engler H; Langstrom B
Doctoral thesis: 2008
Amyloid imaging in Alzheimer’s disease and mild cognitive impairment by positron emission tomography
Forsberg A
Corrigendum: MOLECULAR IMAGING AND BIOLOGY. 2006;8(4):252
Imaging amyloid depositions and glucose uptake changes in Alzheimer's disease:: A follow-up study (vol 8, pg 49, 2006)
Engler H; Forsberg A; Blomquist G; Larsson E; Savitcheva I; Wal A; Nordberg A; Langstrom B
Conference publication: NEUROBIOLOGY OF AGING. 2006;27:S15
Amyloid imaging in MCI patients
Nordberg A; Forsberg A; Hengler H; Wall A; Blomquist G; Langström B
Conference publication: NEUROBIOLOGY OF AGING. 2006;27:S6-S7
Imaging amyloid depositions and glucose uptake in Alzheimer disease:: A follow-up study
Engler H; Forsberg A; Blomquist G; Larsson E; Savitcheva I; Wall A; Langström B; Nordberg A
Conference publication: JOURNAL OF PSYCHOPHARMACOLOGY. 2004;18(3):A6
Measuring amyloid burden in vivo in Alzheimer patients
Nordberg A; Almkvist O; Ausén B; Forsberg A; Kadir A; Engier H; Blomqvist G; Wall A; Långström B

Anställningar

Forskare, Klinisk neurovetenskap, Karolinska Institutet, 2018-

Examina och utbildning

Medicine Doktorsexamen, Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2008

Om mig

Forskningsbeskrivning

Undervisning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI